Combating Parkinson's disease-associated toxicity by modulating proteostasis
- PMID: 28096350
- PMCID: PMC5293013
- DOI: 10.1073/pnas.1620082114
Combating Parkinson's disease-associated toxicity by modulating proteostasis
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Comment on
-
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1165-1170. doi: 10.1073/pnas.1522872114. Epub 2016 Dec 27. Proc Natl Acad Sci U S A. 2017. PMID: 28028237 Free PMC article.
References
-
- Prince M, et al. World Alzheimer Report 2015. Alzheimer’s Disease International; London: 2015. The global impact of dementia; pp. 1–82.
-
- Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013;9(1):25–34. - PubMed
-
- Trinh J, Farrer M. Advances in the genetics of Parkinson disease. Nat Rev Neurol. 2013;9(8):445–454. - PubMed
-
- Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248–264. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical